Pharma's investment in the digital health space is getting more and more real and substantive as companies move beyond the pilot stage and start to launch real digital health interventions, from Teva ...

Representative Susan Wild took to the House floor to challenge the legitimacy of recent insulin price cuts from major pharmaceutical companies and pressure the industry to reduce costs to patients on ...

Pharmaceutical Cliff Diving is a consultancy-style report which identifies, assesses, and provides insights on the key challenges that industry is experiencing now and in the near future. Through CBR ...

Tuesday, Ascendis Pharma A/S (NASDAQ:ASND) reported second-quarter sales of $38.76 million (35.9 million euros), missing the consensus of $92.7 million, down from 47.4 million euros reported a year ...

As more and more partnerships between digital therapeutics and pharma companies begin to emerge, the two industries have started to size each other up. While this may foster an exchange of ideas, ...

Creating great digital experiences in pharma isn’t easy, but progress doesn’t always need to come from big projects or budgets. Here are 5 common challenges that leading digital teams are grappling ...

Quantzig, a leader in delivering scalable analytics and data science services, announced the completion of its new clinical analytics article series. The article offers comprehensive insights into How ...

When it comes to emerging digital and data technologies, most pharma CEOs today are singing from the same hymnal. They all emphasize their commitment to digital transformation, and assert that the ...

LONDON--(BUSINESS WIRE)--SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest article on the inventory related challenges affecting ...

A federal appeals court in Philadelphia rejected challenges by some of New Jersey’s biggest pharmaceutical companies questioning the legality of the federal government requiring drug makers to ...

Cantor Fitzgerald writes that the Skytrofa update probably overshadowed another key update from the call. Achieving breakeven this year is unlikely unless the company significantly reduces costs, ...